CLINICAL EVALUATION OF SERUM p53 ANTIBODIES IN PATIENTS WITH UPPER URINARY TRACT TUMORS
โ Scribed by WATANABE, J; NISHIYAMA, H; KAWANISHI, H; ITO, M; KAMOTO, T; OGAWA, O
- Book ID
- 123603317
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2005
- Tongue
- English
- Weight
- 62 KB
- Volume
- 174
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Mutations of p53 can lead to the production of anti-p53 antibodies in sera of cancer patients. before this study, the value of preoperative serum anti-p53 antibodies in determining the prognoses of patients with gastric carcinoma had yet to be determined. ## Methods: The authors us
Sixty-nine patients who underwent nephroureterectomy for upper urinary tract transitional cell carcinoma were included in the study. The following data were collected for each patient: grade and stage of renalhreteral tumor, tumor location, timing of tumor appearance and recurrence in the bladder, g
## Background: For early detection of ulcerative colitis (uc)-associated colorectal cancer (crc), surveillance colonoscopy is recommended in uc patients at high risk. however, poor acceptability deteriorates its effectiveness and a suitable marker for selecting patients at high risk is needed. here